miR-539 enhances chemosensitivity to cisplatin in non-small cell lung cancer by targeting DCLK1

date of retraction unknown, html page overwrite, date estimated from notifications; see also: https://pubpeer.com/publications/96CACC6C7EAE327217D2319DC364C5; see also: https://www.sciencedirect.com/science/article/pii/S075333222201201X?via%3Dihub; separate retraction notice published later date 4/20/2023;